Results 81 to 90 of about 487,201 (201)
New and old prognostic factors in polycythemia vera
Polycythemia vera is a chronic myeloproliferative disorder affecting people in the sixth decade of life. The disease is considered long-lasting; median survival exceeds 18 years.
PASSAMONTI, FRANCESCO
core
Superior Vena Cava Syndrome in a Patient with Polycytemia Vera: Diagnosis and Treatment
Polycythemia vera is a myeloproliferative disorder characterized by thrombotic complications both in the arterial and venous systems. We report the case of a 55-year-old patient affected by polycythemia vera, presenting with acute superior vena cava ...
Salvatore Lentini +3 more
doaj +1 more source
POLYCYTHEMIA VERA AN EXAMPLE OF A CLINICAL CASE [PDF]
The article concerns a clinical case management of patients with polycythemia vera. The data are given from the laboratory and instrumental diagnostic methods, clinical diagnosis, selection of the optimized treatment and modification of the habit of ...
E. P. Kamenskaya +3 more
core
Extramedullary hematopoiesis and spinal cord compression complicating polycythemia rubra vera.
A 68-year-old man with polycythemia rubra vera developed gradually progressive paraparesis followed by an acute, painless paraplegia. Extradural thoracic spinal cord compression was found to be secondary to extramedullary hematopoiesis (EH).
L. J. P. Assis +3 more
core +1 more source
Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study
BACKGROUND AND OBJECTIVE: It has been suggested that the determination of serum erythropoietin (sEpo) may be useful in distinguishing between polycythemia vera (PV), relative polycythemia and secondary polycythemia (SP), but no conclusive evidence has ...
AF Remacha +5 more
doaj
A rare case of extramedullary hematopoiesis: when the pericardium produces blood cells
Background Cardiac tamponade is an extreme cardiological emergency, fatal in the absence of rapid intervention. This case report highlights a noteworthy and rare correlation between post-polycythemia vera myelofibrosis and extramedullary hematopoiesis ...
SALAH-EDDINE HAYAR +9 more
doaj +1 more source
Subclinical Hypercortisolism among Polycythemia Vera Patients
Background JAK2V617F, a somatic gain-of-function mutation involving the JAK2 tyrosine kinase gene, occurs in nearly all patients with polycythemia vera (PV). JAK2 is also essential in hypothalamo-pituitary-adrenal (HPA) axis system which is known to play
Yasar Yildiz +13 more
core +1 more source
The study of Jak2 V617F mutation in polycythemia vera with zebrafish model
The study of Jak2 V617F mutation in polycythemia vera with zebrafish ...
Yok-Lam Kwong (829219) +6 more
core
Aim: To investigate inflammation indices and erythropoietin levels for their potential role in distinguishing polycythemia vera from secondary polycythemia and to compare different parameter combinations in terms of the diagnostic accuracy. Methods: This
Korhan Kapucu, Emine Gulturk
core +1 more source
INTRODUCTION Polycythemia vera (PV) is a clonal disorder causing overproduction of all three-haematopoietic cell lines, most prominently the red cells in the absence of a recognizable physiological stimulus.
Najia Ahmed +4 more
doaj +2 more sources

